Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3034 |
|
Actual shortage: | 241 (8%) | |
Anticipated shortage: | 18 (1%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2766 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
30 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-MODAFINIL | 100MG | TABLET | Resolved | 2023-08-12 | 2023-10-27 | 201707 |
APO-ROSUVASTATIN | 20MG | TABLET | Resolved | 2023-08-12 | 2023-08-23 | 201710 |
APO-VERAP TAB 80MG | 80MG | TABLET | Resolved | 2023-08-12 | 2023-09-29 | 201713 |
APO-CLOPIDOGREL | 300MG | TABLET | Resolved | 2023-08-12 | 2023-11-17 | 201716 |
APO-VERAP TABLET 120MG | 120MG | TABLET | Resolved | 2023-08-18 | 2023-09-29 | 202400 |
APO-OLANZAPINE | 2.5MG | TABLET | Resolved | 2023-08-18 | 2023-09-28 | 202403 |
APO-TETRABENAZINE | 25MG | TABLET | Resolved | 2023-08-23 | 2023-10-06 | 202818 |
APO-TRAZODONE TABLETS 100MG | 100MG | TABLET | Resolved | 2023-08-23 | 2023-10-06 | 202821 |
APO-ROSUVASTATIN | 40MG | TABLET | Resolved | 2023-08-23 | 2023-09-01 | 202827 |
APO-FLECAINIDE | 50MG | TABLET | Resolved | 2023-09-01 | 2023-09-07 | 203539 |
APO-HYDROMORPHONE | 2MG | TABLET | Resolved | 2023-09-01 | 2023-09-28 | 203548 |
APO-ARIPIPRAZOLE | 15MG | TABLET | Resolved | 2023-09-01 | 2023-09-15 | 203551 |
APO-CARVEDILOL | 12.5MG | TABLET | Resolved | 2023-09-01 | 2023-11-17 | 203554 |
APO-MEDROXY | 10MG | TABLET | Resolved | 2023-09-01 | 2023-12-22 | 203557 |
APO-DAPAGLIFLOZIN | 10MG | TABLET | Resolved | 2023-09-01 | 2024-01-05 | 203563 |
APO-ACYCLOVIR | 400MG | TABLET | Actual shortage | 2023-09-01 | 2023-09-01 | 203566 |
APO-CINACALCET | 60MG | TABLET | Resolved | 2023-09-07 | 2023-10-15 | 203809 |
APO-METHYLPHENIDATE | 10MG | TABLET | Resolved | 2023-09-07 | 2023-10-20 | 203812 |
APO-ARIPIPRAZOLE | 10MG | TABLET | Resolved | 2023-09-07 | 2024-01-19 | 203816 |
APO-MEDROXY TABLETS | 2.5MG | TABLET | Resolved | 2023-09-07 | 2023-12-01 | 203822 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-LOPERAMIDE | 2MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4930 |
APO-SOTALOL | 80MG | TABLET | Discontinued | 2017-03-31 | 2018-12-07 | 4936 |
APO-ACEBUTOLOL | 400MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4965 |
APO-OLANZAPINE | 5.0MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4968 |
APO-SOTALOL | 160MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4971 |
APO-TERAZOSIN | 2MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4974 |
APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2019-06-12 | 40778 |
APO-METFORMIN | 500MG | TABLET | To be discontinued | 2018-02-23 | 2018-12-28 | 40781 |
APO-METFORMIN | 500MG | TABLET | To be discontinued | 2018-02-23 | 2018-12-28 | 40784 |
APO-METFORMIN | 500MG | TABLET | Discontinued | 2018-02-23 | 2018-11-26 | 40790 |
APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40796 |
APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40811 |
APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40814 |
APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40817 |
APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40820 |
APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40823 |